ArcticZymes Technologies — Director's Dealing 2016

Sep 7, 2016

Biotec Pharmacon - Mandatory notification of trade

Biotec Pharmacon - Mandatory notification of trade

(Tromsø 07. September 2016) Børge Sørvoll, CFO of Biotec Pharmacon has purchased

4.503 shares at NOK 11.10 per share. After this transaction holds Børge

Sørvoll 5.652 shares and 82.500 options in Biotec Pharmacon

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

For further information, please contact

Børge Sørvoll

CFO

+47 952 90 187

borge.sorvoll@biotec.no